TRIAMCINOLONE ACET 200 MG/5 ML
TRIAMCINOLONE ACET 200 MG/5 ML, a generic anti-inflammatory steroid, has a NADAC acquisition cost of $3.99, though hospital charges typically range 5-20x higher than acquisition costs.
About the analyst
Priya Iyengar leads the billing code review team at BillRazor Research. She analyzes NCCI bundling edits, DRG coding, and regional rate variation. Expertise: NCCI bundling, DRG analysis, regional pricing.
Triamcinolone acetonide is an anti-inflammatory steroid used to treat various inflammatory conditions including arthritis, allergies, and skin disorders. This generic formulation typically generates lower reimbursement rates compared to brand-name alternatives, with Medicare benchmark pricing varying significantly across different care settings.
No credit card required. Results in 60 seconds.
Related pricing data
Data source: National Average Drug Acquisition Cost (NADAC) survey, published by CMS. HCPCS drug pricing codes from Medicare Part B Drug Average Sales Price file.
What NADAC means: The average price pharmacies pay to acquire this drug from wholesalers. Hospital charges for the same drug are typically higher due to facility fees, compounding, and administration costs.
Limitations: NADAC reflects pharmacy acquisition cost, not patient out-of-pocket cost. Insurance copays, formulary tiers, and manufacturer rebates affect what patients actually pay.